Phibro Animal Health Corporation (PAHC) Price Target Cut to $44 by Citi Amid Sector Pressure
TheFly reported on May 13 that PAHC had its price objective reduced to $44 from $62 by Citi in a sector research update, with a Neutral rating maintained on the stock.






